Intraarterial injection of amrinone for vasospasm induced by subarachnoid hemorrhage

American Journal of Neuroradiology

Volumn 18, Issue 3, 1997, Pages 492-496

  Yoshida, Kenshi ^a   Watanabe, Hiroshi ^a   Nakamura, Saburo ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Drugs, intraarterial injection; Subarachnoid space, hemorrhage; Vasospasm

Indexed keywords

AMRINONE;

ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN SCINTISCANNING; BRAIN VASOSPASM; CASE REPORT; CLINICAL FEATURE; CONFUSION; FEMALE; HEADACHE; HUMAN; MALE; SUBARACHNOID HEMORRHAGE;

ADULT; AMRINONE; ANEURYSM, RUPTURED; BRAIN; CEREBRAL ANGIOGRAPHY; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INJECTIONS, INTRA-ARTERIAL; INTRACRANIAL ANEURYSM; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PAPAVERINE; REGIONAL BLOOD FLOW; SUBARACHNOID HEMORRHAGE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT FAILURE; VASODILATOR AGENTS;

EID: 0030900171     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Kaku Y, Yonekawa Y, Tsukahara T, Kazekawa K. Superselective intra-arterial infusion of papaverine for treatment of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 1992;77: 842-847
2. Kassell MF, Helm G, Simmons N, Phillips D, Cail WS. Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg 1992;77:848-852
3. Zubkov YN, Nikiforov BM, Shustin VA. Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH. Acta Neurochir (Wien) 1984;70:65-79
4. Yamaoto Y, Smith RR, Bernanke DH. Mechanism of action of balloon angioplasty in cerebral vasospasm. Neurosurgery 1992; 30:1-6
5. White RP. Vasospasm I: experimental findings. In: Fox JL, ed. Intracranial Aneurysms. New York, NY: Springer; 1983:218-249
6. Nakagomi T, Kassell NF, Hongo K, Sasaki T. Pharmacological reversibility of experimental cerebral vasospasm. Neurosurgery 1990;27:582-586
7. Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 1968;28: 14-20
8. Heffez DS, Leong KW. Sustained release of papaverine for the treatment of cerebral vasospasm. J Neurosurg 1992;77:783-787
9. Vorkapic P, Bevan RD, Bevan JA. Longitudinal time course of reversible and irreversible components of chronic cerebrovasospasm of the rabbit basilar artery. J Neurosurg 1991;74:951-955
10. Silver PJ. Biochemical aspects of inhibition of cardiovascular low Km cyclic adenosine monophosphate phosphodiesterase. Am J Cardiol 1989;63:2A-8A
11. Kuriyama H, Ito Y, Suzuki H, Kitamura K, Itoh T. Factors modifying contraction-relaxation cycle in vascular smooth muscle. Am J Physiol 1982;243:H641-H662
12. Kauffman RF, Schenck KW, Utterback BG, Crowe VG, Cohen ML. In vitro vascular relaxation by new inotropic agents: relationship to phosphodiesterase inhibition and cyclic nucleotides. J Pharmacol Exp Ther 1987;242:864-872
13. Silver PJ, Lepore RE, O'Connor B, et al. Inhibition of the low Km cAMP phosphodiesterase and activation of the cyclic AMP system in vascular smooth muscle by amrinone. J Pharmacol Exp Ther 1988;247:34-42
14. Toda N, Nakajima M, Nishimura K, Miyazaki M. Response of isolated dog arteries to amrinone. Cardiovasc Res 1984;18:174-182
15. Weishaar RE, Burrows SD, Kobylarz DC, Quade MM, Evans DB. Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and in platelets. Biochem Pharmacol 1986;35:787-800